Viyash Scientific partners with Boehringer Ingelheim to sell its companion animal products in India
With over 3,000 employees, Viyash Scientific Limited’s portfolio comprises formulations and Active Pharmaceutical Ingredients for human and veterinary use, across 100-pluse countries.
Alivira Animal Health Limited, a wholly owned subsidiary of Viyash Scientific Limited, has partnered with Boehringer Ingelheim India to distribute its companion animal products in the country.
The partnership aims to capture India’s growing pet healthcare market, driven by increased pet ownership, rising awareness of preventive care and emphasis on animal well-being across the country, the company said.
Viyash Scientific Limited was formerly SeQuent Scientific Limited. It has been officially renamed Viyash Scientific Limited from January 8, 2026, marking the completion of the merger between Sequent Scientific Limited and Viyash Life Sciences Private Limited.
Dr Haribabu Bodepudi, Managing Director and Group Chief Executive, Viyash Scientific Limited, said, “India offers tremendous opportunities for innovative medicines which cater to the medical needs of our pets. Driving access to high quality solutions for our pets in urban and rural India is at the heart of this partnership.”
Alivira’s extensive geographical reach and on-ground capabilities combined with Boehringer Ingelheim’s differentiated companion animal product portfolio would add to its ability to serve veterinarians and pet parents, he added.
Dr Vinod Gopal, Country Head, Animal Health, Boehringer Ingelheim India, said, “This partnership aligns with our long-term growth strategy for the animal health business in India. It positions us to scale efficiently while remaining focused on strategic leadership. Alivira Animal Health Limited will expand our sales capability across urban and rural India in the companion animal business, further enhancing market reach.”
With over 3,000 employees, Viyash Scientific Limited’s portfolio comprises formulations and Active Pharmaceutical Ingredients for human and veterinary use, across 100-pluse countries. Viyash and its subsidiaries have manufacturing, research and distribution operations across India, Spain, Brazil, Turkey and USA, the company said.
Published on January 22, 2026
